GSTM2 is a key molecular determinant of resistance to SG-ARIs.
Oncogene
; 41(40): 4498-4511, 2022 09.
Article
in En
| MEDLINE
| ID: mdl-36038661
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Resistance, Neoplasm
/
Androgen Receptor Antagonists
/
Prostatic Neoplasms, Castration-Resistant
/
Glutathione Transferase
Type of study:
Prognostic_studies
Limits:
Humans
/
Male
Language:
En
Journal:
Oncogene
Journal subject:
BIOLOGIA MOLECULAR
/
NEOPLASIAS
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: